Replies to post #248 on InterMune Inc. (ITMN)

[ghmm]

Your welcome, you've saved me from listening to quite a few calls!

Other then the starting dose and what if (which was obvious) nothing notable.

Still waiting for you to say if Novartis had anything noteworthy (pertinent to MNTA) :)